May 30, 2013

An organization set up to provide pharmacy services in the wake of natural disasters is prepared for what experts predict will be a particularly bad hurricane season.

May 30, 2013

The year is only halfway done, but 2013 is already proving to be a year of particular importance for generic drugs as the industry awaits two important decisions from the Supreme Court and continues to wait for federal biosimilar regulations while fending off efforts to limit the scope of their use at the state level.

May 30, 2013

Stop & Shop has launched a card to help customers save money on prescription drugs, days after sister-chain Giant Food of Landover, Md., did the same.

May 29, 2013

British drug maker GlaxoSmithKline has acquired Swiss vaccine development company Okairos for $325 million, GSK said Wednesday.

May 29, 2013

Mylan Specialty is extending a marketing campaign around its line of emergency treatments for severe allergic reactions.

May 29, 2013

The National Community Pharmacists Association and RxWiki, a leading pharmacy media network, announced a new partnership that will offer digital solutions to more than 23,000 community pharmacies across the country.

May 28, 2013

Anglo-Swedish drug maker AstraZeneca will buy Omthera Pharmaceuticals for $323 million, the two companies said.

May 28, 2013

A federal court has blocked Actavis from distributing its generic version of a drug for treating asthma, the company said.

May 28, 2013

Giant Food is offering discounts at the pharmacy counter with a new card available for a one-time enrollment fee, the supermarket chain said.

May 28, 2013

Canadian drug maker Valeant Pharmaceuticals International is buying U.S.-based Bausch & Lomb Holdings for $8.7 billion, the companies said Monday.

May 23, 2013

Forest Labs president and CEO Howard Solomon will retire at the end of 2013, the company said.

May 23, 2013

Aftershocks from last year's nationwide outbreak of fungal meningitis linked to a Massachusetts-based compounding pharmacy continued to be felt in a House subcommittee meeting Thursday.

May 23, 2013

Johnson & Johnson expects to file for Food and Drug Administration approval of more than 10 new drugs over the next four years, the drug maker said Thursday.

May 23, 2013

In anticipation of new treatments for hepatitis C, a growing number of physicians have begun intentionally delaying treatment for patients, according to a new study.

May 23, 2013

The Touro College of Pharmacy awarded three graduating students for their research into drug interactions, pneumonia treatment and access to birth control pills.

May 22, 2013

Irish drug maker Elan is paying about $380 million to buy two drug makers, the company said.

May 22, 2013

A new vaccine against pneumococcal disease appears as safe as an older one, according to a new study.

May 22, 2013

Generic drug maker Par Pharmaceutical Cos. has started shipping an authorized generic version of a heart-disease medication made by AstraZeneca.

May 21, 2013

A federal appellate court has ruled in favor of Mylan in a case involving a drug for chronic obstructive pulmonary disease, the drug maker said.

May 21, 2013

Impax Labs has launched an authorized generic drug for migraine headaches under a partnership with AstraZeneca, Impax said.

May 21, 2013

Drug maker Duchesnay USA has launched a new treatment for morning sickness, the company announced.

May 21, 2013

A subsidiary of drug maker Mylan is sponsoring a campaign to draw attention to severe allergic reactions.

May 21, 2013

Spending on specialty drugs is likely to increase by 67% over the next couple of years, according to a new study by pharmacy benefit manager Express Scripts.

May 20, 2013

Actavis will acquire Warner Chilcott for $8.5 billion, the drug maker said.